Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net loss	$ (10,123,249)	$ (8,047,299)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	78,233	70,840
Stock-based compensation expense	584,297	385,605
Change in deferred income taxes	(1,675,381)	(485,216)
Changes in operating assets and liabilities:
Prepaid expenses, deposits, and other assets	(224,224)	352,252
Accounts payable, accrued expenses, and other liabilities	1,202,283	303,466
Net cash used in operating activities	(10,158,041)	(7,420,352)
Cash flows provided by financing activities:
Proceeds from the sale of common stock	10,827,100	5,731,779
Proceeds from the exercise of common stock warrants	8,046,103
Payment of issuance costs	(982,328)	(162,829)
Net cash provided by financing activities	17,890,875	5,568,950
Net increase (decrease) in cash and cash equivalents	7,732,834	(1,851,402)
Cash and cash equivalents at beginning of period	14,177,349	7,991,172
Cash and cash equivalents at end of period	21,910,183	6,139,770
Supplemental disclosure of non-cash investing and financing activities:
Operating lease right of use asset and current and noncurrent liability		$ 334,205